Sort By

  • Newest

  • Newest

  • Oldest

  • Author Name

  • Author Name

  • David Chaplin

  • Drew Meredith

  • Giselle Roux

  • Greg Bright

  • James Dunn

  • Lachlan Maddock

ASX update; COVID-19 impacting Macquarie Group

Vaccine trial restart boosts markets, ASX strength to continue, COVID-19 impacting Macquarie Group A positive lead from Wall Street and news that AstraZeneca plc (NYSE:AZN) had resumed their vaccine trial sent the ASX 200 (ASX:XJO) 0.7% higher on Monday. Positive news on the vaccine front support the energy and industrial sectors amid hope of a…
Drew Meredith | 14th Sep 2020 | More
Financial Planner’s market update – ASX to open strongly

The ASX 200 (ASX:XJO) finished 0.5% higher behind a strong rally in financials, up 2.5%, following positive comments on a potential COVID-19 treatment.
Drew Meredith | 26th Aug 2020 | More